Abstract
Background: Due to its effective osteogenic ability, BMP9 is a promising candidate for bone regeneration medicine. Whereas, BMP9 can also induce adipogenesis simultaneously. LCN2 is a cytokine associated with osteogenesis and adipogenesis. Reducing the adipogenic potential may be a feasible measure to enhance the osteogenic capability of BMP9.
Objective: The objective of the study was to explore the role of LCN2 in regulating the BMP9-initialized osteogenic and adipogenic differentiation in mouse embryonic fibroblasts (MEFs), and clarify the possible underlying mechanism.
Methods: Histochemical stain, western blot, real-time PCR, laser confocal, immunoprecipitation, cranial defect repair, and fetal limb culture assays were used to evaluate the effects of LCN2 on BMP9-induced osteogenic and adipogenic differentiation, as well as Wnt/β-catenin signaling.
Results: LCN2 was down-regulated by BMP9. The BMP9-induced osteogenic markers were inhibited by LCN2 overexpression, but the adipogenic markers were increased; LCN2 knockdown exhibited opposite effects. Similar results were found in bone defect repair and fetal limb culture tests. The level of β-catenin nucleus translocation was found to be reduced by LCN2 overexpression, but increased by LCN2 knockdown. The inhibitory effect of LCN2 overexpression on the osteogenic capability of BMP9 was reversed by β-catenin overexpression; whereas, the effect of LCN2 knockdown on promoting BMP9 osteogenic potential was almost eliminated by β-catenin knockdown. LCN2 could bind with LRP6 specifically, and the inhibitory effect of LCN2 on the osteogenic potential of BMP9 could not be enhanced by LRP6 knockdown.
Conclusion: LCN2 inhibits the BMP9-induced osteogenic differentiation but promotes its adipogenic potential in MEFs, which may be partially mediated by reducing Wnt/β-catenin signaling via binding with LRP6.
Graphical Abstract
[1]
Shibuya N, Jupiter DC. Bone graft substitute: Allograft and xenograft. Clin Podiatr Med Surg 2015; 32(1): 21-34.
[http://dx.doi.org/10.1016/j.cpm.2014.09.011] [PMID: 25440415]
[http://dx.doi.org/10.1016/j.cpm.2014.09.011] [PMID: 25440415]
[2]
Shao J, Zhang W, Yang T. Using mesenchymal stem cells as a therapy for bone regeneration and repairing. Biol Res 2015; 48(1): 62.
[http://dx.doi.org/10.1186/s40659-015-0053-4] [PMID: 26530042]
[http://dx.doi.org/10.1186/s40659-015-0053-4] [PMID: 26530042]
[3]
Zhu L, Liu Y, Wang A, et al. Application of BMP in bone tissue engineering. Front Bioeng Biotechnol 2022; 10: 810880.
[http://dx.doi.org/10.3389/fbioe.2022.810880] [PMID: 35433652]
[http://dx.doi.org/10.3389/fbioe.2022.810880] [PMID: 35433652]
[4]
Zhang L, Luo Q, Shu Y, et al. Transcriptomic landscape regulated by the 14 types of bone morphogenetic proteins (BMPs) in lineage commitment and differentiation of mesenchymal stem cells (MSCs). Genes Dis 2019; 6(3): 258-75.
[http://dx.doi.org/10.1016/j.gendis.2019.03.008] [PMID: 32042865]
[http://dx.doi.org/10.1016/j.gendis.2019.03.008] [PMID: 32042865]
[5]
Cecchi S, Bennet SJ, Arora M. Bone morphogenetic protein-7: Review of signalling and efficacy in fracture healing. J Orthop Translat 2016; 4: 28-34.
[http://dx.doi.org/10.1016/j.jot.2015.08.001] [PMID: 30035063]
[http://dx.doi.org/10.1016/j.jot.2015.08.001] [PMID: 30035063]
[6]
Fu R, Selph S, McDonagh M, et al. Effectiveness and harms of recombinant human bone morphogenetic protein-2 in spine fusion: A systematic review and meta-analysis. Ann Intern Med 2013; 158(12): 890-902.
[http://dx.doi.org/10.7326/0003-4819-158-12-201306180-00006] [PMID: 23778906]
[http://dx.doi.org/10.7326/0003-4819-158-12-201306180-00006] [PMID: 23778906]
[7]
Woo EJ. Recombinant human bone morphogenetic protein-2: Adverse events reported to the Manufacturer and User Facility Device Experience database. Spine J 2012; 12(10): 894-9.
[http://dx.doi.org/10.1016/j.spinee.2012.09.052] [PMID: 23098616]
[http://dx.doi.org/10.1016/j.spinee.2012.09.052] [PMID: 23098616]
[8]
Kang Q, Sun MH, Cheng H, et al. Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery. Gene Ther 2004; 11(17): 1312-20.
[http://dx.doi.org/10.1038/sj.gt.3302298] [PMID: 15269709]
[http://dx.doi.org/10.1038/sj.gt.3302298] [PMID: 15269709]
[9]
Liang K, Du Y, Chen L, et al. Contrary roles of Wnt/β-catenin signaling in BMP9-induced osteogenic and adipogenic differentiation of 3T3-L1 preadipocytes. Cell Biochem Biophys 2020; 78(3): 347-56.
[http://dx.doi.org/10.1007/s12013-020-00935-0] [PMID: 32720112]
[http://dx.doi.org/10.1007/s12013-020-00935-0] [PMID: 32720112]
[10]
Wang J, Liao J, Zhang F, Song D, Lu M, Liu J, et al. NEL-like molecule-1 (Nell1) is regulated by bone morphogenetic protein 9 (BMP9) and potentiates BMP9-induced osteogenic differentiation at the expense of adipogenesis in mesenchymal stem cells. Cellular Physiology and Biochemistry: Int J Experimen Cell Physiol Biochem Pharmacol 2017; 41(2): 484-500.
[11]
Mostafa S, Pakvasa M, Coalson E, et al. The wonders of BMP9: From mesenchymal stem cell differentiation, angiogenesis, neurogenesis, tumorigenesis, and metabolism to regenerative medicine. Genes Dis 2019; 6(3): 201-23.
[http://dx.doi.org/10.1016/j.gendis.2019.07.003] [PMID: 32042861]
[http://dx.doi.org/10.1016/j.gendis.2019.07.003] [PMID: 32042861]
[12]
Wang H, Hu Y, He F, et al. All-trans retinoic acid and COX-2 cross-talk to regulate BMP9-induced osteogenic differentiation via Wnt/β-catenin in mesenchymal stem cells. Biomed Pharmacother 2019; 118: 109279.
[13]
Jaberi S, Cohen A, D’Souza C, et al. Lipocalin-2: Structure, function, distribution and role in metabolic disorders. Biomed Pharmacother 2021; 142: 112002.
[14]
Mosialou I, Shikhel S, Liu JM, et al. MC4R-dependent suppression of appetite by bone-derived lipocalin 2. Nature 2017; 543(7645): 385-90.
[http://dx.doi.org/10.1038/nature21697] [PMID: 28273060]
[http://dx.doi.org/10.1038/nature21697] [PMID: 28273060]
[15]
Costa D, Principi E, Lazzarini E, et al. LCN2 overexpression in bone enhances the hematopoietic compartment via modulation of the bone marrow microenvironment. J Cell Physiol 2017; 232(11): 3077-87.
[http://dx.doi.org/10.1002/jcp.25755] [PMID: 28004388]
[http://dx.doi.org/10.1002/jcp.25755] [PMID: 28004388]
[16]
Rucci N, Capulli M, Piperni S, et al. Lipocalin 2: A new mechanoresponding gene regulating bone homeostasis. J Bone Miner Res 2015; 30(2): 357-68.
[17]
Capulli M, Ponzetti M, Maurizi A, et al. A complex role for lipocalin 2 in bone metabolism: Global ablation in mice induces osteopenia caused by an altered energy metabolism. J Bone Miner Res 2018; 33(6): 1141-53.
[18]
Szklarczyk D, Gable AL, Lyon D, et al. STRING v11: Protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res 2019; 47(D1): D607-13.
[http://dx.doi.org/10.1093/nar/gky1131] [PMID: 30476243]
[http://dx.doi.org/10.1093/nar/gky1131] [PMID: 30476243]
[19]
Shannon P, Markiel A, Ozier O, et al. Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Res 2003; 13(11): 2498-504.
[http://dx.doi.org/10.1101/gr.1239303] [PMID: 14597658]
[http://dx.doi.org/10.1101/gr.1239303] [PMID: 14597658]
[20]
Luo J, Deng ZL, Luo X, et al. A protocol for rapid generation of recombinant adenoviruses using the AdEasy system. Nat Protoc 2007; 2(5): 1236-47.
[http://dx.doi.org/10.1038/nprot.2007.135] [PMID: 17546019]
[http://dx.doi.org/10.1038/nprot.2007.135] [PMID: 17546019]
[21]
He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, Vogelstein B. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 1998; 95(5): 2509-14.
[http://dx.doi.org/10.1073/pnas.95.5.2509] [PMID: 9482916]
[http://dx.doi.org/10.1073/pnas.95.5.2509] [PMID: 9482916]
[22]
Nishimura I, Hisanaga R, Sato T, et al. Effect of osteogenic differentiation medium on proliferation and differentiation of human mesenchymal stem cells in three-dimensional culture with radial flow bioreactor. Regen Ther 2015; 2: 24-31.
[http://dx.doi.org/10.1016/j.reth.2015.09.001] [PMID: 31245456]
[http://dx.doi.org/10.1016/j.reth.2015.09.001] [PMID: 31245456]
[23]
Li FS, Li PP, Li L, Deng Y, Hu Y, He BC. PTEN reduces BMP9-induced osteogenic differentiation through inhibiting Wnt10b in mesenchymal stem cells. Front Cell Dev Biol 2021; 8: 608544.
[http://dx.doi.org/10.3389/fcell.2020.608544] [PMID: 33614622]
[http://dx.doi.org/10.3389/fcell.2020.608544] [PMID: 33614622]
[24]
Shi L, Karrar E, Wang X. Sesamol ameliorates hepatic lipid accumulation and oxidative stress in steatosis HepG2 cells via the PPAR signaling pathway. J Food Biochem 2021; 45(11): e13976.
[http://dx.doi.org/10.1111/jfbc.13976] [PMID: 34664288]
[http://dx.doi.org/10.1111/jfbc.13976] [PMID: 34664288]
[25]
Assefa F, Lim J, Kim JA, et al. Secretoneurin, a neuropeptide, enhances bone regeneration in a mouse calvarial bone defect model. Tissue Eng Regen Med 2021; 18(2): 315-24.
[http://dx.doi.org/10.1007/s13770-020-00304-1] [PMID: 33145742]
[http://dx.doi.org/10.1007/s13770-020-00304-1] [PMID: 33145742]
[26]
Chen L, Jiang W, Huang J, He B, Zuo G, Zhang W, et al. Insulin-like growth factor 2 (IGF-2) potentiates BMP-9-induced osteogenic differentiation and bone formation. J Bone Miner Res 2010; 25(11): 2447-59.
[27]
Shao Y, Chen QZ, Zeng YH, et al. All-trans retinoic acid shifts rosiglitazone-induced adipogenic differentiation to osteogenic differentiation in mouse embryonic fibroblasts. Int J Mol Med 2016; 38(6): 1693-702.
[http://dx.doi.org/10.3892/ijmm.2016.2782] [PMID: 27779644]
[http://dx.doi.org/10.3892/ijmm.2016.2782] [PMID: 27779644]
[28]
Chella Krishnan K, Sabir S, Shum M, et al. Sex-specific metabolic functions of adipose Lipocalin-2. Mol Metab 2019; 30: 30-47.
[http://dx.doi.org/10.1016/j.molmet.2019.09.009] [PMID: 31767179]
[http://dx.doi.org/10.1016/j.molmet.2019.09.009] [PMID: 31767179]
[29]
Yan QW, Yang Q, Mody N, et al. The adipokine lipocalin 2 is regulated by obesity and promotes insulin resistance. Diabetes 2007; 56(10): 2533-40.
[http://dx.doi.org/10.2337/db07-0007] [PMID: 17639021]
[http://dx.doi.org/10.2337/db07-0007] [PMID: 17639021]
[30]
Zhang J, Wu Y, Zhang Y, LeRoith D, Bernlohr DA, Chen X. The role of lipocalin 2 in the regulation of inflammation in adipocytes and macrophages. Mol Endocrinol 2008; 22(6): 1416-26.
[http://dx.doi.org/10.1210/me.2007-0420] [PMID: 18292240]
[http://dx.doi.org/10.1210/me.2007-0420] [PMID: 18292240]
[31]
Choi E, Jeong J, Jang H, et al. Skeletal lipocalin-2 is associated with iron-related oxidative stress in ob/ob mice with sarcopenia. Antioxidants 2021; 10(5): 758.
[32]
Tencerova M, Figeac F, Ditzel N, Taipaleenmäki H, Nielsen T, Kassem M. High-fat diet-induced obesity promotes expansion of bone marrow adipose tissue and impairs skeletal stem cell functions in mice. J Bone Miner Res 2018; 33(6): 1154-65.
[http://dx.doi.org/10.1002/jbmr.3408]
[http://dx.doi.org/10.1002/jbmr.3408]
[33]
Kang Q, Song WX, Luo Q, et al. A comprehensive analysis of the dual roles of BMPs in regulating adipogenic and osteogenic differentiation of mesenchymal progenitor cells. Stem Cells Dev 2009; 18(4): 545-58.
[http://dx.doi.org/10.1089/scd.2008.0130] [PMID: 18616389]
[http://dx.doi.org/10.1089/scd.2008.0130] [PMID: 18616389]
[34]
Rodríguez JP, Astudillo P, Ríos S, Seitz G, Pino AM. Adipogénesis y osteoporosis. Rev Med Chil 2009; 137(6): 827-36.
[http://dx.doi.org/10.4067/S0034-98872009000600015] [PMID: 19746287]
[http://dx.doi.org/10.4067/S0034-98872009000600015] [PMID: 19746287]
[35]
Meurer SK, Tezcan O, Lammers T, Weiskirchen R. Differential regulation of lipocalin 2 (LCN2) in doxorubicin-resistant 4T1 triple negative breast cancer cells. Cell Signal 2020; 74: 109731.
[http://dx.doi.org/10.1016/j.cellsig.2020.109731] [PMID: 32758668]
[http://dx.doi.org/10.1016/j.cellsig.2020.109731] [PMID: 32758668]
[36]
Liao YP, Du WM, Hu Y, et al. CREB/Wnt10b mediates the effect of COX‐2 on promoting BMP9‐induced osteogenic differentiation via reducing adipogenic differentiation in mesenchymal stem cells. J Cell Biochem 2019; 120(6): 9572-87.
[http://dx.doi.org/10.1002/jcb.28234] [PMID: 30525243]
[http://dx.doi.org/10.1002/jcb.28234] [PMID: 30525243]
[37]
Zhu JH, Liao YP, Li FS, et al. Wnt11 promotes BMP9‐induced osteogenic differentiation through BMPs/Smads and p38 MAPK in mesenchymal stem cells. J Cell Biochem 2018; 119(11): 9462-73.
[http://dx.doi.org/10.1002/jcb.27262] [PMID: 30010216]
[http://dx.doi.org/10.1002/jcb.27262] [PMID: 30010216]
[38]
Regard JB, Zhong Z, Williams BO, Yang Y. Wnt signaling in bone development and disease: Making stronger bone with Wnts. Cold Spring Harb Perspect Biol 2012; 4(12): a007997.
[http://dx.doi.org/10.1101/cshperspect.a007997] [PMID: 23209148]
[http://dx.doi.org/10.1101/cshperspect.a007997] [PMID: 23209148]
[39]
Tejeda-Muñoz N, Robles-Flores M. Glycogen synthase kinase 3 in Wnt signaling pathway and cancer. IUBMB Life 2015; 67(12): 914-22.
[http://dx.doi.org/10.1002/iub.1454] [PMID: 26600003]
[http://dx.doi.org/10.1002/iub.1454] [PMID: 26600003]
[40]
Ma J, Chen J, Xue K, et al. LCN2 mediates skin inflammation in psoriasis through the SREBP2‒NLRC4 axis. J Invest Dermatol 2022; 142(8): 2194-2204.e11.
[http://dx.doi.org/10.1016/j.jid.2022.01.012] [PMID: 35120997]
[http://dx.doi.org/10.1016/j.jid.2022.01.012] [PMID: 35120997]
[41]
Semënov MV, Tamai K, Brott BK, Kühl M, Sokol S, He X. Head inducer dickkopf-1 is a ligand for Wnt coreceptor LRP6. Curr Biol 2001; 11(12): 951-61.
[http://dx.doi.org/10.1016/S0960-9822(01)00290-1] [PMID: 11448771]
[http://dx.doi.org/10.1016/S0960-9822(01)00290-1] [PMID: 11448771]
[42]
Zhang ZH, Jia XY, Fang JY, et al. Reduction of SOST gene promotes bone formation through the Wnt/β‐catenin signalling pathway and compensates particle‐induced osteolysis. J Cell Mol Med 2020; 24(7): 4233-44.
[http://dx.doi.org/10.1111/jcmm.15084] [PMID: 32134561]
[http://dx.doi.org/10.1111/jcmm.15084] [PMID: 32134561]
